Skip to content
RDL Network logo
Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world population — Francesco Vitiello (2025) | RDL Network